Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin effects on emotional and reward-related brain processes in PTSD
NL-OMON39817Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Emotional face matching task BOLD response, Reward task BOLD response and 6 more. Started Jul 2012; status: active, not recruiting.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON39817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39817.